Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis

Publisher Name

Experimental Neurology

more of publication

Increased Permeability of the Blood–Brain Barrier in a Diabetic Mouse Model (Leprdb/db Mice)

by Musaad A. Alshammari , Abdulaziz O. Alshehri, Faleh Alqahtani , Mohammad R. Khan, Muhammed A. Bakhrebah , Fawaz Alasmari , Tahani K. Alshammari and Shakir D. Alsharari

2024

Published in:

International Journal of Molecular Science

Cathepsin-B inhibitor CA-074 attenuates retinopathy and optic neuritis in experimental autoimmune encephalomyelitis induced in SJL/J mice

by Mohammad Rashid Khan, Sheikh Fayaz Ahmad, Ahmed Nadeem, Faisal Imam, Naif O. Al-Harbi, Mohd Shahnawaz Khan, Meshal Alsahli, Khaled Alhosaini

2023

Published in:

Saudi Pharmaceutical Journal

Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis

by Mushtaq A. Ansari, Ahmed Nadeem, Musaad A. Alshammari, Sabry M. Attia, Saleh A. Bakheet, Mohammad R. Khan, Thamer H. Albekairi, Abdullah F. Alasmari, Khaled Alhosaini, Faleh Alqahtani, Haneen A. Al-Mazroua, Sheikh F. Ahmad

2022

Published in:

Experimental Neurology